QR Code (код быстрого отклика)

Medication Adherence and Antithrombotic Therapy Outcomes

Background: The AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease) trial demonstrated that rivaroxaban monotherapy has noninferior efficacy and superior safety compared with combination therapy (rivaroxaban plus a single antiplatelet) in...

Полное описание

Сохранить в:
Главные авторы: Naoki Chiba, MD, Takashi Noda, MD, PhD, Kotaro Nochioka, MD, PhD, Koichi Kaikita, MD, PhD, Masaharu Akao, MD, PhD, Junya Ako, MD, PhD, Tetsuya Matoba, MD, PhD, Masato Nakamura, MD, PhD, Katsumi Miyauchi, MD, PhD, Nobuhisa Hagiwara, MD, PhD, Kazuo Kimura, MD, PhD, Kunihiko Matsui, MD, MPH, Hisao Ogawa, MD, PhD, Satoshi Yasuda, MD, PhD
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2026-03-01
Серии:JACC: Asia
Предметы:
atrial fibrillation
bleeding
coronary artery disease
medication adherence
monotherapy
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S2772374725007045
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы